Overview

The GMO U.S. Equity Fund seeks to generate high total return by investing primarily in U.S. equities. The Fund’s benchmark is the S&P 1500 Index.

The Fund’s investment approach is grounded in the Global Equity team’s belief that, in the short term, equity markets exhibit exploitable inefficiencies as a result of irrational investor actions, the imperfect flow of information, and the participation of non-economic actors, while in the long term returns are ultimately driven by economic reality. The Fund aims to take advantage of this inefficiency by utilizing a multi-factor valuation model in conjunction with other methods, such as cross-asset signals and corporate alerts, to identify mispriced equity securities.

Facts

Doc Table
Fund Inception Date September 18, 1985
Fund Total Assets as of 31/10/2020 $343mm USD
Benchmark S&P Composite 1500

Share Class III

Inception Date September 16, 2005
Ticker Symbol GMUEX
CUSIP 362013658
NAV as of 25/11/2020 13.27
Net Expense Ratio 1 0.46
Gross Expense Ratio 2 0.49
Minimum Investment Size $5mm in GMO

1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2021. Elimination of this reimbursement will result in higher fees and lower performance.

2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2020.

Performance

Quarter-End as of September 30, 2020(USD, %) | U.S. Equity Fund-III

Table Caption
1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 7.28 7.29 10.85 11.35 10.75
S&P Composite 1500 13.42 11.33 13.58 13.46
Russell 3000 15.00 11.64 13.68 13.48 11.05
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

If certain expenses were not reimbursed, performance would be lower. Transaction costs, if any, are paid to the fund to offset the cost of portfolio transactions to invest or raise cash.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Quarter-End as of September 30, 2020(USD, %) | U.S. Equity Fund-III

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 5.96 0.10 7.28 7.29 10.85 11.35 10.75
S&P Composite 1500 8.56 4.13 13.42 11.33 13.58 13.46
Russell 3000 9.21 5.41 15.00 11.64 13.68 13.48 11.05
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Quarter-End as of September 30, 2020(USD, %) | U.S. Equity Fund-III

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund 6.08 0.45 7.78 7.79 11.36 11.86 11.28
S&P Composite 1500 8.56 4.13 13.42 11.33 13.58 13.46
Russell 3000 9.21 5.41 15.00 11.64 13.68 13.48 11.05
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Month-End as of October 31, 2020(USD, %) | U.S. Equity Fund-III

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund -3.25 -3.25 -3.16 2.50 5.01 8.31 10.51 10.62
S&P Composite 1500 -2.28 -2.28 1.76 8.56 9.65 11.30 12.78
Russell 3000 -2.16 -2.16 3.14 10.15 10.04 11.48 12.80 10.95
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Month-End as of October 31, 2020(USD, %) | U.S. Equity Fund-III

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
U.S. Equity Fund -3.22 -3.22 -2.78 2.98 5.50 8.82 11.02 11.15
S&P Composite 1500 -2.28 -2.28 1.76 8.56 9.65 11.30 12.78
Russell 3000 -2.16 -2.16 3.14 10.15 10.04 11.48 12.80 10.95
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Year Ending December 31 (USD, %) | U.S. Equity Fund-III

Calendar
U.S. Equity Fund S&P Composite 1500 Russell 3000
2019 28.57 30.90 31.02
2018 -9.78 -4.96 -5.24
2017 18.46 21.13 21.13
2016 13.58 13.03 12.74
2015 0.65 1.01 0.48
2014 9.27 13.08 12.56
2013 29.61 32.80 33.55
2012 12.81 16.17 16.42
2011 8.07 1.75 1.03
2010 8.82 16.38 16.93
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Year Ending December 31 (USD, %) | U.S. Equity Fund-III

Calendar
U.S. Equity Fund S&P Composite 1500 Russell 3000
2019 29.16 30.90 31.02
2018 -9.36 -4.96 -5.24
2017 19.00 21.13 21.13
2016 14.10 13.03 12.74
2015 1.11 1.01 0.48
2014 9.77 13.08 12.56
2013 30.20 32.80 33.55
2012 13.32 16.17 16.42
2011 8.57 1.75 1.03
2010 9.32 16.38 16.93
  • U.S. Equity Fund 1
  • S&P Composite 1500
  • Russell 3000

Inception Date: September 18, 1985

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of April 1, 2020, the U.S. Equity Fund changed its benchmark so that the Fund now seeks to generate high total return in excess of that of the S&P 1500 Index. The Fund formerly sought to outperform the Russell 3000 Index. Performance information presented is that of Class III shares of GMO U.S. Core Fund for all periods ending on or before September 16, 2005.

Documents

Literature

Fact Sheet Download
Prospectus Download
Summary Prospectus Download
Statement of Additional Information Download
XBRL 485(b) Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Commentary - Quarterly Download
Market Review Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download

Investor Information

Annual Report Download
Semiannual Report Download
NAVs and Distributions Download
Distribution Dates Download
Tax-Related Distribution Information Download
Download All Download

Risks

Risks associated with investing in the Fund may include: (1) Market Risk - Equities: The market price of an equity may decline due to factors affecting the issuer or its industry or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Management and Operational Risk: The risk that GMO's investment techniques will fail to produce desired results. (3) Focused Investment Risk: The Fund invests its assets in the securities of a limited number of issuers, and a decline in the market price of a particular security held by the Fund may affect the Fund's performance more than if the Fund invested in the securities of a larger number of issuers. For a more complete discussion of these risks and others, please consult the Fund's prospectus.

Disclosures

An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above.

The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.